CANAQUEST MEDICAL CORP announces filing of INTERNATIONAL CANNABIS PATENT
September 17, 2019 09:00 ET
|
CanaQuest Medical Corp
A NOVEL BOTANICAL AND TETRAHYDROCANNABINOL (“THC”) FORMULATION FOR THE REDUCTION OF CANNABIS-INDUCED NEGATIVE NEUROPSYCHIATRIC SIDE-EFFECTS Research & development a primary focus for this medical...
Former Principal Deputy Commissioner of FDA, Dr. Rachel Sherman, Joins Aptinyx Board of Directors
September 04, 2019 07:27 ET
|
Aptinyx Inc.
EVANSTON, Ill., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct Offering
August 23, 2019 09:00 ET
|
Seelos Therapeutics, Inc.
NEW YORK, Aug. 23, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company, announced today that it has entered into a securities purchase...
Aptinyx Reports Second Quarter 2019 Financial Results and Highlights
August 12, 2019 06:33 ET
|
Aptinyx Inc.
Reported that NYX-2925 met primary and secondary endpoints in Phase 2 fibromyalgia study On track to initiate three additional Phase 2 studies in 2H 2019 across pipeline of CNS product candidates ...
Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference
August 06, 2019 08:33 ET
|
Aptinyx Inc.
EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
Seelos Therapeutics Reports Q2 2019 Pipeline Update
August 01, 2019 09:00 ET
|
Seelos Therapeutics, Inc.
NEW YORK, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, today released its second quarter pipeline update. “We have made...
Susan Kenney Certified as a Brain Health Coach by Amen Clinics
July 30, 2019 08:00 ET
|
Emergo Recovery
BARRIE, Ontario, July 30, 2019 (GLOBE NEWSWIRE) -- Susan Kenney, Co-Founder and Director of Therapeutic Wellness at Emergo Recovery, has been certified by Amen Clinics as a Brain Health Coach. The...
Dave Kenney Certified as a Brain Health Coach by Amen Clinics
July 16, 2019 08:00 ET
|
Emergo Recovery
BARRIE, Ontario, July 16, 2019 (GLOBE NEWSWIRE) -- Dave Kenney, Executive Director and CEO at Emergo Recovery, has been certified by Amen Clinics as a Brain Health Coach. The Brain Health Coaching...
Aptinyx Presents Preclinical Data Demonstrating Robust Activity of NYX-783 on Alcohol-Seeking Behavior and Relapse-Like Behavior in Multiple Models of Alcohol Use Disorder
June 26, 2019 08:03 ET
|
Aptinyx Inc.
EVANSTON, Ill., June 26, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
Canbiola Appoints David Woycik, Jr. to its Corporate Advisory Board and Completes a 300% Increased Investment in its Duramed Division to Combat the Opioid Crisis
May 06, 2019 11:12 ET
|
Canbiola, Inc.
Adds Pharmaceutical and Business Operations Expertise with Key Relationships to Provide Growth Opportunities for Canbiola HICKSVILLE, NY, May 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...